Scar tissue prevention and revision - introduction to a special issue

References

[1] Gurtner GC,Barrandon Y.Wound repair and regeneration.Nature2008;453:314-21

[2] Wilgus TA.Inflammation as an orchestrator of cutaneous scar formation: a review of the literature.Plast Aesthet Res2020;7:54 PMCID:PMC7592345

[3] Qian LW,Yamane K,Chan RK.Exacerbated and prolonged inflammation impairs wound healing and increases scarring.Wound Repair Regen2016;24:26-34

[4] Zhang Q,Kelly AP.Tumor-like stem cells derived from human keloid are governed by the inflammatory niche driven by IL-17/IL-6 axis.PLoS One2009;4:e7798 PMCID:PMC2771422

[5] Dong X,Ma S.Mast cell chymase in keloid induces profibrotic response via transforming growth factor-β1/Smad activation in keloid fibroblasts.Int J Clin Exp Pathol2014;7:3596-607 PMCID:PMC4128972

[6] Amini-Nik S,Jeschke MG.Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.Adv Drug Deliv Rev2018;123:135-54 PMCID:PMC5742037

[7] Roques C.The use of corticosteroids to treat keloids: a review.Int J Low Extrem Wounds2008;7:137-45

[8] Yuan Z,Chen Y,Cui W.Regulating inflammation using acid-responsive electrospun fibrous scaffolds for skin scarless healing.Mediators Inflamm2014;2014:858045 PMCID:PMC3984856

[9] Rahmani-Neishaboor E,Hartwell R,Carr N.Topical application of a film-forming emulgel dressing that controls the release of stratifin and acetylsalicylic acid and improves/prevents hypertrophic scarring.Wound Repair Regen2013;21:55-65

[10] Wang J,Ding J.Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring.J Cell Physiol2011;226:1265-73

[11] Ding J,Zhang R.Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of postburn hypertrophic scar (HTS).Wound Repair Regen2011;19:568-78

[12] Dorati R,DeLuca PP.Development of a Topical 48-H Release Formulation as an Anti-scarring Treatment for Deep Partial-Thickness Burns.AAPS PharmSci Tech2018;19:2264-75

[13] Ud-Din S,Mazhari M.A double-blind, randomized trial shows the role of zonal priming and direct topical application of epigallocatechin-3-gallate in the modulation of cutaneous scarring in human skin.J Invest Dermatol2019;139:1680-90.e16

[14] Pang X,Zheng Z.Small leucine-rich proteoglycans in skin wound healing.Front Pharmacol2019;10:1649 PMCID:PMC6997777

[15] Gurtner GC,Wong VW.Improving cutaneous scar formation by controlling the mechanical environment: large animal and phase I studies.Ann Surg2011;254:217-25

[16] Breuing K,Liu P.Healing of partial thickness porcine skin wounds in a liquid environment.J Surg Res1992;52:50-8

[17] Dohi T,Akaishi S.The interplay of mechanical stress, strain, and stiffness at the keloid periphery correlates with increased caveolin-1/ROCK signaling and scar progression.Plast Reconstr Surg2019;144:58e-67e

[18] Fu S,Fan J.Mechanotransduction in wound healing: From the cellular and molecular level to the clinic.Adv Skin Wound Care2021;34:67-74

[19] Neumann CG.The expansion of an area of skin by progressive distention of a subcutaneous balloon; use of the method for securing skin for subtotal reconstruction of the ear.Plast Reconstr Surg1957;19:124-30

[20] Oranges CM,Tremp M,Kalbermatten DF.The Impact of Recipient Site External Expansion in Fat Grafting Surgical Outcomes.Plast Reconstr Surg Glob Open2018;6:e1649 PMCID:PMC5865941

[21] Panayi AC,Orgill DP.Evidence based review of negative pressure wound therapy.J Dermatol2017;6:1-16

[22] Huang C,Hyakusoku H.Small-wave incision method for linear hypertrophic scar reconstruction: a parallel-group randomized controlled study.Aesthetic Plast Surg2012;36:387-95

[23] Aarabi S,Gurtner GC.Hypertrophic scar formation following burns and trauma: new approaches to treatment.PLoS Med2007;4:e234 PMCID:PMC1961631

[24] Mirastschijski U,Rinkevich Y,Sorg H.Wound repair and scarring of genital skin.Plast Aesthet Res2020;7:70

[25] Lawrence JW,Schomer K.Epidemiology and impact of scarring after burn injury: a systematic review of the literature.J Burn Care Res2012;33:136-46

[26] Gauglitz GG,Pavicic T,Jeschke MG.Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.Mol Med2011;17:113-25 PMCID:PMC3022978

[27] Sainsbury DC.Body image and facial burns.Adv Skin Wound Care2009;22:39-44; quiz 45

[28] Wong J,Ding J.Prevention and management of scarring after thermal injury.Plast Aesthet Res2021;8:9

[29] So K,Bush JA.Avotermin for scar improvement following scar revision surgery: a randomized, double-blind, within-patient, placebo-controlled, phase II clinical trial.Plast Reconstr Surg2011;128:163-72

[30] Meier K.Emerging new drugs for wound repair.Expert Opin Emerg Drugs2006;11:23-37

[31] Sun ZL,Zou ML.Emerging Role of IL-10 in Hypertrophic Scars.Front Med (Lausanne)2020;7:438 PMCID:PMC7481393

[32] Li Z.Cell therapy for severe burn wound healing.Burns Trauma2018;6:13 PMCID:PMC5971426

[33] Januszyk M,Bhatt KA.Mechanical offloading of incisional wounds is associated with transcriptional downregulation of inflammatory pathways in a large animal model.Organogenesis2014;10:186-93 PMCID:PMC4154952

[34] Lemperle G.Prevention of hyper- and hypotrophic scars through surgical incisions in the direction of the “main folding lines” of the skin.Plast Aesthet Res2020;7:40

[35] Langer K.On the anatomy and physiology of the skin.Br J Plast Surg1978;31:277-8

[36] Kraissl CJ.Excision of small tumors of the skin of the face with special reference to the wrinkle lines.Surgery1949;25:592-600

[37] Yang Y,Liu W.Psychological stress enhances keloid development via stress hormone-induced abnormal cytokine profiles and inflammatory responses.Plast Aesthet Res2020;7:34